Biopotential- A Breakthrough in Cardiovascular Diagnostics

Cardiovascular disease remains the world's leading cause of death. Millions of people develop heart disease gradually, often without symptoms until irreversible damage has occurred.

Traditional screening methods often identify disease after structural damage has already progressed.

Biopotential is developing a new generation of non-invasive diagnostic technology designed to identify subtle cardiovascular changes earlier.

Developed by cardiovascular surgeon Dr. Heikki Riekkinen, Biopotential combines decades of cardiovascular research with patented innovations that improve the reliability and clinical value of EKG measurements.

The technology focuses on improving reproducibility and interpreting EKG amplitude changes that can provide valuable insights into cardiovascular health. Unlike conventional approaches, Biopotential addresses measurement variability, enabling more accurate long-term monitoring. 

 ✓ Non-invasive detection of symptomless blood loss

✓ Reproducible EKG electrode placement

✓ Long-term EKG amplitude correction

✓ Next-generation myocardial elasticity assessment